Merck & Co., Inc. (NYSE:MRK) is walking away from nearly $7 million in taxpayer-funded state and local incentives aimed at luring to Austin a major …
Category: Health
Pfizer Inc. (NYSE:PFE) announced top-line results from a Phase 4 study (CrisADe CARE 1) which showed that crisaborole ointment, 2%, was well-tolerated in children aged …
Neuralstem, Inc. (NASDAQ:CUR) announced the publication of a manuscript in Stem Cells Translational Medicine describing the results of an open label Phase 1 clinical trial …
Gilead Sciences, Inc. (NASDAQ:GILD)announced afternoon that it plans to ask the Food and Drug Administration to approve an arthritis drug this year. Gilead, in partnership …
PTC Therapeutics, Inc. (NASDAQ:PTCT) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has completed their review …
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has been granted approval by the Food and Drug Administration for Soliris. Soliris (eculizumab) is an injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder …
Pfizer Inc. (NYSE:PFE) said the U.S. Food and Drug Administration has approved its oncology biosimilar Zirabev for the treatment of five types of cancer. The …
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced the completion of target enrollment of 198 participants for its pivotal Phase 3 registration trial (“REVEAL 1”) of VGX-3100, a novel …
Acasti Pharma Inc. (NASDAQ:ACST) loss for fiscal 2019 expanded from $21.5 million in the prior year to $51.6 million due to higher R&D costs for the TRILOGY Phase …
Akorn, Inc. (NASDAQ:AKRX) said that it received a warning letter from the Food and Drug Administration related to the inspection of its Somerset, New Jersey manufacturing …
AbbVie Inc. (NYSE:ABBV) and Allergan plc announced that the companies have entered into a definitive transaction agreement under which AbbVie will acquire Allergan in a cash and stock transaction for …
Bristol-Myers Squibb Company (NYSE:BMY) provided update on approval process with Celgene Corporation
Bristol-Myers Squibb Company (NYSE:BMY) provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation. The Company remains actively engaged in …
Lehigh Valley Health Network and CVS Health Corporation (NYSE:CVS) announced a five-year partnership Monday to share patient data to design programs aimed at lowering costs …
Affimed N.V. (NASDAQ:AFMD) declined after announcing clinical data update on lead product candidate AFM13 in CD30+ lymphoma at the ICML 2019. Affimed N.V. (NASDAQ:AFMD), a Healthcare sector …
Minerva Neurosciences, Inc. (NASDAQ:NERV) seltorexant helped patients fall asleep more quickly and stay asleep for longer, beating placebo and Sanofi’s insomnia med Ambien in a phase 2b …
